Acute neutrophilic airway inflammation is associated with a decrease in pulmonary ascorbic acid concentration but not an elevation of exhaled hydrogen peroxide Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004
Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002
Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001
N -acetyl-L-cysteine reduces the increased vascular permeability and VEGF levels in lungs treated with hydrogen peroxideSource: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel in vitro assays and results from animal models Year: 2007
Levels of superoxide dismutase and malondialdehyde in patients with primary spontaneous pneumothorax Source: Eur Respir J 2002; 20: Suppl. 38, 283s Year: 2002
Malondialdehyde and nitrotyrosine as markers of peroxynitrite activity in sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017
Enhanced level of hydrogen peroxide in expired breath correlates with the plasma concentration of TNFa in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis Source: Eur Respir J 2001; 17: 1201-1207 Year: 2001
Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008
Induced sputum glutathione levels are decreased in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001
Exhaled 8-isoprostane in sarcoidosis. Relation to superoxide anion production by bronchoalveolar lavage cells Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009
Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA Source: Eur Respir J 2016; 47: 1014-1015 Year: 2016
Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA Source: Eur Respir J 2016; 47: 1012-1014 Year: 2016
The role of superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels in the differentiation of benign-malign pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 439s Year: 2002
Increased concentration of hydrogen peroxide (H2 O2 ) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001
Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005
Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2003; 22: 457-461 Year: 2003
Non-enzymatic hydrogen peroxide scavenging properties of normal human airway secretions Source: Eur Respir J 2003; 22: Suppl. 45, 456s Year: 2003
Manganese superoxide dismutase is increased in the airways of smokers' lungs Source: Eur Respir J 2004; 24 : 765-771 Year: 2004